Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of pemetrexed and gemcitabine in treatment-resistant KRAS-mutant metastatic colorectal cancer
2010-018700-90Phase 2Terminated
- Sponsor
- Vejle Hospital
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pemetrexed and gemcitabine in colorectal cancer (CRC), sponsored by Vejle Hospital. Started Feb 2010; status: terminated.
02
Drugs
pemetrexedgemcitabine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2010-018700-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018700-90.